Page last updated: 2024-09-04

canertinib and Leukemia, Lymphocytic, T Cell

canertinib has been researched along with Leukemia, Lymphocytic, T Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gréen, A; Gréen, H; Hallbeck, AL; Holmlund, B; Jönsson, JI; Severinsson, EA; Trinks, C; Walz, TM	1

Other Studies

1 other study(ies) available for canertinib and Leukemia, Lymphocytic, T Cell

Article	Year
The pan-ErbB tyrosine kinase inhibitor canertinib induces caspase-mediated cell death in human T-cell leukemia (Jurkat) cells. Biochemical and biophysical research communications, 2011, Jul-08, Volume: 410, Issue:3 Topics: Apoptosis; Caspases; Humans; Jurkat Cells; Leukemia, T-Cell; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Morpholines; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Receptor Protein-Tyrosine Kinases; Receptors, Antigen, T-Cell; ZAP-70 Protein-Tyrosine Kinase	2011

Article

Year

The pan-ErbB tyrosine kinase inhibitor canertinib induces caspase-mediated cell death in human T-cell leukemia (Jurkat) cells.

Biochemical and biophysical research communications, 2011, Jul-08, Volume: 410, Issue:3

Topics: Apoptosis; Caspases; Humans; Jurkat Cells; Leukemia, T-Cell; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Morpholines; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Receptor Protein-Tyrosine Kinases; Receptors, Antigen, T-Cell; ZAP-70 Protein-Tyrosine Kinase

2011